AMEX:NHC (USA)

National Healthcare Corp

$ 83.56 0 (0%)
Volume: 14,545 Avg Vol (1m): 34,360
Market Cap $: 1.28 Bil Enterprise Value $: 1.16 Bil
P/E (TTM): 15.36 P/B: 1.72
Earnings Power Value 91.89
Net Current Asset Value -15.38
Tangible Book 47.55
Projected FCF 65.93
Median P/S Value 63.94
Graham Number 76.29
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7.4/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 2.49
Cash-To-Debt range over the past 10 years
Min: 0, Med: 2.04, Max: 33.85
Current: 2.49
0
33.85
Equity-to-Asset 0.57
Equity-to-Asset range over the past 10 years
Min: 0.16, Med: 0.49, Max: 0.72
Current: 0.57
0.16
0.72
Debt-to-Equity 0.11
Debt-to-Equity range over the past 10 years
Min: 0.02, Med: 0.2, Max: 3.06
Current: 0.11
0.02
3.06
Debt-to-EBITDA 0.52
Debt-to-EBITDA range over the past 10 years
Min: 0.08, Med: 0.25, Max: 1.23
Current: 0.52
0.08
1.23
Interest Coverage 13.77
Interest Coverage range over the past 10 years
Min: 12.07, Med: 52.23, Max: 235.24
Current: 13.77
12.07
235.24
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.07
DISTRESS
GREY
SAFE
Beneish M-Score -2.14
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 7.66%
WACC 3.57%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 6.12
Operating Margin range over the past 10 years
Min: 6.12, Med: 7.89, Max: 10.25
Current: 6.12
6.12
10.25
Net Margin % 8.42
Net Margin range over the past 10 years
Min: 5.47, Med: 6.07, Max: 8.42
Current: 8.42
5.47
8.42
ROE % 11.53
ROE range over the past 10 years
Min: 6.23, Med: 8.05, Max: 11.53
Current: 11.53
6.23
11.53
ROA % 7.40
ROA range over the past 10 years
Min: 4.74, Med: 5.31, Max: 7.65
Current: 7.4
4.74
7.65
ROC (Joel Greenblatt) % 20.49
ROC (Joel Greenblatt) range over the past 10 years
Min: 14.33, Med: 17.36, Max: 23.36
Current: 20.49
14.33
23.36
3-Year Total Revenue Growth Rate 2.60
3-Year Revenue Growth Rate range over the past 10 years
Min: -3.6, Med: 3.5, Max: 11.1
Current: 0.9
-3.6
11.1
3-Year Total EBITDA Growth Rate -0.90
3-Year EBITDA Growth Rate range over the past 10 years
Min: -21.6, Med: 4.5, Max: 18
Current: -2.6
-21.6
18
3-Year EPS w/o NRI Growth Rate 6.50
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 5.5, Max: 106.4
Current: 6.5
0
106.4

» NHC's 30-Y Financials

Financials (Next Earnings Date: 2019-08-09)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with AMEX:NHC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Health Care Providers    NAICS : 623311    SIC : 8051
Compare NYSE:BKD TSX:SIA NZSE:SUM NYSE:CIVI OSTO:AMBEA NZSE:MET TSX:EXE ASX:REG XPAR:LNA ASX:EHE NZSE:OCA NZSE:ARV TSE:2398 TSE:6062 ASX:JHC NYSE:GEN TSE:7061 NYSE:CSU TSE:9707 TSE:8769
Traded in other countries
Address 100 East Vine Street, Murfreesboro, TN, USA, 37130
National HealthCare Corp (NHC) operates skilled nursing facilities and assisted and independent living facilities in the Southeastern, Northeastern, and Midwestern regions of the United States. Its skilled nursing facilities generate the majority of revenue. These facilities offer medical services and 24-hour nursing care, in addition to therapy and social services. NHC also provides rehabilitative services, in which licensed therapists provide physical, speech, and occupational therapies for patients recovering from illnesses, injuries, or disabilities. The company's assisted and independent living facilities and homecare programs provide assistance with daily activities to its patients.

Ratios

Current vs industry vs history
PE Ratio (TTM) 15.36
PE Ratio range over the past 10 years
Min: 7.84, Med: 16.54, Max: 24.61
Current: 15.36
7.84
24.61
PE Ratio without NRI 15.36
PE without NRI range over the past 10 years
Min: 7.84, Med: 16.54, Max: 24.61
Current: 15.36
7.84
24.61
Price-to-Owner-Earnings 14.41
Price-to-Owner-Earnings range over the past 10 years
Min: 8.79, Med: 16.47, Max: 37.58
Current: 14.41
8.79
37.58
PB Ratio 1.72
PB Ratio range over the past 10 years
Min: 1.01, Med: 1.47, Max: 2.12
Current: 1.72
1.01
2.12
PS Ratio 1.29
PS Ratio range over the past 10 years
Min: 0.61, Med: 0.99, Max: 1.3
Current: 1.29
0.61
1.3
Price-to-Free-Cash-Flow 18.67
Price-to-Free-Cash-Flow range over the past 10 years
Min: 9.28, Med: 17.68, Max: 128.93
Current: 18.67
9.28
128.93
Price-to-Operating-Cash-Flow 13.22
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.59, Med: 9.95, Max: 14.22
Current: 13.22
5.59
14.22
EV-to-EBIT 10.50
EV-to-EBIT range over the past 10 years
Min: 4.3, Med: 9.9, Max: 16.6
Current: 10.5
4.3
16.6
EV-to-EBITDA 7.59
EV-to-EBITDA range over the past 10 years
Min: 3.4, Med: 7, Max: 10
Current: 7.59
3.4
10
EV-to-Revenue 1.17
EV-to-Revenue range over the past 10 years
Min: 0.6, Med: 1, Max: 1.4
Current: 1.17
0.6
1.4
Shiller PE Ratio 22.02
Shiller PE Ratio range over the past 10 years
Min: 12.74, Med: 18.94, Max: 30.72
Current: 22.02
12.74
30.72
Current Ratio 1.92
Current Ratio range over the past 10 years
Min: 0.89, Med: 1.72, Max: 3.52
Current: 1.92
0.89
3.52
Quick Ratio 1.88
Quick Ratio range over the past 10 years
Min: 0.85, Med: 1.69, Max: 3.43
Current: 1.88
0.85
3.43
Days Sales Outstanding 37.26
Days Sales Outstanding range over the past 10 years
Min: 32.62, Med: 33.9, Max: 38.78
Current: 37.26
32.62
38.78

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 2.44
Trailing Dividend Yield range over the past 10 years
Min: 1.8, Med: 2.58, Max: 3.7
Current: 2.44
1.8
3.7
Dividend Payout Ratio 0.37
Dividend Payout Ratio range over the past 10 years
Min: 0.3, Med: 0.43, Max: 0.61
Current: 0.37
0.3
0.61
3-Year Dividend Growth Rate (Per Share) 0.70
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 4.6, Max: 42.1
Current: 0.7
0
42.1
Forward Dividend Yield % 2.50
N/A
Yield-on-Cost (5-Year) % 3.84
Yield-on-Cost (5y) range over the past 10 years
Min: 2.83, Med: 4.06, Max: 5.82
Current: 3.84
2.83
5.82
3-Year Share Buyback Rate -0.50
3-Year Share Buyback Rate range over the past 10 years
Min: -10.8, Med: -2.2, Max: -0.1
Current: -0.5
-10.8
-0.1

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 1.76
Price-to-Tangible-Book range over the past 10 years
Min: 0.6, Med: 1.61, Max: 10.43
Current: 1.76
0.6
10.43
Price-to-Projected-FCF 1.27
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.27, Med: 0.99, Max: 8.18
Current: 1.27
0.27
8.18
Price-to-Median-PS-Value 1.31
Price-to-Median-PS-Value range over the past 10 years
Min: 0.09, Med: 0.8, Max: 1.31
Current: 1.31
0.09
1.31
Price-to-Graham-Number 1.10
Price-to-Graham-Number range over the past 10 years
Min: 0.34, Med: 1.04, Max: 3.99
Current: 1.1
0.34
3.99
Earnings Yield (Joel Greenblatt) % 9.51
Earnings Yield (Greenblatt) range over the past 10 years
Min: 6, Med: 10.1, Max: 23.1
Current: 9.51
6
23.1
Forward Rate of Return (Yacktman) % 2.06
Forward Rate of Return range over the past 10 years
Min: 0.8, Med: 11, Max: 16.4
Current: 2.06
0.8
16.4

More Statistics

Revenue (TTM) (Mil) $ 985.67
EPS (TTM) $ 5.44
Beta 0.29
Volatility % 14.57
52-Week Range $ 69.57 - 86.53
Shares Outstanding (Mil) 14.11

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y